NantHealth, Inc. (NHIQ)
Total Valuation
NantHealth has a market cap or net worth of $11.04 million. The enterprise value is $279.60 million.
Market Cap | 11.04M |
Enterprise Value | 279.60M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
NantHealth has 27.47 million shares outstanding. The number of shares has increased by 94.84% in one year.
Shares Outstanding | 27.47M |
Shares Change (YoY) | +94.84% |
Shares Change (QoQ) | +94.84% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 4.33% |
Float | 7.03M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.17 |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 4.35 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.08
Current Ratio | 0.08 |
Quick Ratio | 0.06 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -3.03 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -44.50% |
Return on Capital (ROIC) | -183.59% |
Revenue Per Employee | $176,088 |
Profits Per Employee | -$192,803 |
Employee Count | 365 |
Asset Turnover | 0.41 |
Inventory Turnover | n/a |
Taxes
Income Tax | -264,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.43% in the last 52 weeks. The beta is 1.53, so NantHealth's price volatility has been higher than the market average.
Beta (1Y) | 1.53 |
52-Week Price Change | -81.43% |
50-Day Moving Average | 0.34 |
200-Day Moving Average | 0.42 |
Relative Strength Index (RSI) | 48.98 |
Average Volume (30 Days) | 3,668 |
Short Selling Information
The latest short interest is 37,953, so 0.14% of the outstanding shares have been sold short.
Short Interest | 37,953 |
Short Previous Month | 44,921 |
Short % of Shares Out | 0.14% |
Short % of Float | 0.54% |
Short Ratio (days to cover) | 6.13 |
Income Statement
In the last 12 months, NantHealth had revenue of $64.27 million and -$70.37 million in losses. Loss per share was -$8.26.
Revenue | 64.27M |
Gross Profit | 39.35M |
Operating Income | -44.44M |
Pretax Income | -70.64M |
Net Income | -70.37M |
EBITDA | -39.28M |
EBIT | -53.13M |
Loss Per Share | -$8.26 |
Balance Sheet
The company has $5.82 million in cash and $274.38 million in debt, giving a net cash position of -$268.56 million or -$9.78 per share.
Cash & Cash Equivalents | 5.82M |
Total Debt | 274.38M |
Net Cash | -268.56M |
Net Cash Per Share | -$9.78 |
Equity / Book Value | -250.18M |
Book Value Per Share | -9.11 |
Working Capital | -175.76M |
Cash Flow
In the last 12 months, operating cash flow was -$27.64 million and capital expenditures -$4.38 million, giving a free cash flow of -$32.02 million.
Operating Cash Flow | -27.64M |
Capital Expenditures | -4.38M |
Free Cash Flow | -32.02M |
FCF Per Share | -$2.13 |
Margins
Gross margin is 61.22%, with operating and profit margins of -69.14% and -109.49%.
Gross Margin | 61.22% |
Operating Margin | -69.14% |
Pretax Margin | -109.90% |
Profit Margin | -109.49% |
EBITDA Margin | -61.12% |
EBIT Margin | -82.66% |
FCF Margin | -49.81% |
Dividends & Yields
NantHealth does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -94.84% |
Shareholder Yield | -94.84% |
Earnings Yield | -637.24% |
FCF Yield | -289.92% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 16, 2022. It was a reverse split with a ratio of 1:15.
Last Split Date | Dec 16, 2022 |
Split Type | Reverse |
Split Ratio | 1:15 |
Scores
NantHealth has an Altman Z-Score of -13.32 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -13.32 |
Piotroski F-Score | 4 |